DrugPatentWatch Database Preview
Par Pharm Company Profile
What is the competitive landscape for PAR PHARM, and what generic alternatives to PAR PHARM drugs are available?
PAR PHARM has two hundred and fifteen approved drugs.
There is one US patent protecting PAR PHARM drugs. There are fourteen tentative approvals on PAR PHARM drugs.
There are nine patent family members on PAR PHARM drugs in eight countries and one hundred and sixteen supplementary protection certificates in twelve countries.
Summary for Par Pharm
| International Patents: | 9 |
| US Patents: | 1 |
| Tradenames: | 129 |
| Ingredients: | 126 |
| NDAs: | 215 |
| Patent Litigation for Par Pharm: | See patent lawsuits for Par Pharm |
| PTAB Cases with Par Pharm as petitioner: | See PTAB cases with Par Pharm as petitioner |
Drugs and US Patents for Par Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | HYDROXYZINE PAMOATE | hydroxyzine pamoate | CAPSULE;ORAL | 087657-001 | Jun 11, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Par Pharm Inc | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207169-003 | Oct 29, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Par Pharm | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 077494-003 | Oct 26, 2009 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Par Pharm | HYDRA-ZIDE | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088946-001 | Oct 21, 1985 | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Par Pharm | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 088698-001 | Sep 25, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Par Pharm | ISOSORBIDE DINITRATE | isosorbide dinitrate | TABLET;ORAL | 086925-001 | Mar 12, 1987 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Par Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Par Pharm Inc | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 5,612,367 | ➤ Sign Up |
| Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-007 | Jun 13, 1995 | 4,215,104 | ➤ Sign Up |
| Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | 4,258,027 | ➤ Sign Up |
| Par Pharm Inc | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 5,482,963 | ➤ Sign Up |
| Par Pharm Inc | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 6,143,775 | ➤ Sign Up |
| Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-003 | Approved Prior to Jan 1, 1982 | 5,238,924 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PAR PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Nasal Spray | 500 mcg/spray | ➤ Subscribe | 2017-04-28 |
| ➤ Subscribe | Tablets | 10 mg and 20 mg | ➤ Subscribe | 2008-02-29 |
International Patents for Par Pharm Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2006115626 | ➤ Sign Up |
| China | 101163679 | ➤ Sign Up |
| Mexico | 2007013118 | ➤ Sign Up |
| Japan | 2008538560 | ➤ Sign Up |
| Canada | 2605413 | ➤ Sign Up |
| Japan | 5378788 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Par Pharm Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 07C/043 | Belgium | ➤ Sign Up | PRODUCT NAME: AMLODIPINE ET VALSARTAN; NATL. REGISTRATION NO/DATE: EU/1/06/370/001 20070118; FIRST REGISTRATION: CH 57771 20061222 |
| C/GB97/088 | United Kingdom | ➤ Sign Up | PRODUCT NAME: TOLCAPONE; REGISTERED: CH 54055/01 19970225; CH 54055/02 19970225; UK EU/1/97/044/001 19970827; UK EU/1/97/044/002 19970827; UK EU/1/97/044/003 19970827; UK EU/1/97/044/004 19970827; UK EU/1/97/044/005 19970827; UK EU/1/97/044/006 19970827 |
| C0005 | Belgium | ➤ Sign Up | PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204 |
| C0041 | France | ➤ Sign Up | PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418 |
| C/GB98/033 | United Kingdom | ➤ Sign Up | PRODUCT NAME: ZAFIRLUKAST AND OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT.; REGISTERED: IE PA 51/67/1 19960103; UK 12619/0108 19980605 |
| C/GB11/015 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
